Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

August 31, 2015

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

Dexamethasone

8mg IV dexamethesone given

DRUG

Placebo

Subjects randomized to placebo receive 50cc normal saline

Trial Locations (1)

10065

Weill Cornell Medical College, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT01734161 - Dexamethasone for the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Cesarean Sections | Biotech Hunter | Biotech Hunter